NVIDIA-invested AI pharmaceutical company Iambic completes U.S.IPO, IPO 150000000 USD
Iambic Therapeutics issued approximately 16 USD shares at a per-share price of 9380000, in the United States IPO IPO 150000000 USD, and is expected to trade on Nasdaq on October 15 under the ticker IAM.